High‐resolution array CGH identifies novel regions of genomic alteration in intermediate‐risk prostate cancer
Adrian Ishkanian(University of Miami), Robert G. Bristow(Princess Margaret Cancer Centre), Jcm Ho(Queen Mary Hospital), Theodorus van der Kwast(Erasmus MC), Michael Milosevic(Princess Margaret Cancer Centre), Monique Albert(Ontario Institute for Cancer Research), Chad A. Mallof, Amena Syed(University Health Network), Maisa Yoshimoto(University of Alberta), Jeremy A. Squire(Universidade de São Paulo), Alice Meng(University Health Network), Wan L. Lam(University of British Columbia)
Cited by 80
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705